Department of Justice Files Amended Response to Public Comments in Antitrust Suit Against OhioHealth Corporation

The United States Department of Justice Antitrust Division, alongside the State of Ohio, has advanced its antitrust enforcement proceedings against OhioHealth Corporation by filing an amended response to public comments regarding a proposed final judgment. Submitted to the United States District Court for the Southern District of Ohio, the amended filing addresses four public comments concerning the proposed remedy that seeks to dismantle alleged anticompetitive contracting practices in the Columbus healthcare sector.

Background and Procedural History

The legal challenge originated on February 20, 2026, when federal and state plaintiffs filed a civil antitrust complaint alleging that OhioHealth violated Section 1 of the Sherman Act. The complaint asserts that the healthcare corporation engaged in anticompetitive steering and transparency restrictions that diminished consumer choice and suppressed price competition for medical services in the greater Columbus region.

Following months of litigation maneuvering, the parties filed a proposed final judgment and a consent stipulation on June 16, 2026. A competitive impact statement followed in July, prompting publication in the Federal Register and major regional newspapers to initiate the mandatory 60-day public comment period under the Antitrust Procedures and Penalties Act, commonly known as the Tunney Act. The government received four public comments on the proposed remedy. Although the Department of Justice filed its initial response on October 20, 2026, it subsequently filed an amended version to incorporate a comment that was inadvertently omitted from the original document.

Legal Standard and Judicial Review

Under the framework of the Tunney Act, federal consent judgments in antitrust cases require judicial approval to ensure they align with the public interest. The statute directs courts to evaluate specific factors, including the competitive impact of the judgment, enforcement provisions, and the effect on competition within the relevant market.

Decisional law emphasizes that judicial review under the Tunney Act is narrow and deferential. Precedents such as United States v. Microsoft Corp. establish that courts must afford broad discretion to the executive branch in settling antitrust litigation and assessing litigation risks. A district court is not authorized to conduct a de novo review of the facts or to redesign the settlement to achieve an optimal outcome. Instead, the judicial inquiry is limited to determining whether the government's chosen remedies are reasonable, clear, and within the outer reaches of the public interest.

Scope of the Proposed Remedy

The proposed final judgment targets the specific anti-competitive provisions identified in the government complaint. If entered by United States District Judge Algenon L. Marbley, the decree will void existing steering and transparency restrictions imposed by OhioHealth. Furthermore, the judgment will permanently prohibit the healthcare provider from seeking or enforcing such provisions in future contracts and from penalizing insurance payors that engage in patient steering or offer price transparency initiatives to their members.

The Department of Justice maintains that these injunctive provisions provide an appropriate and effective remedy for the alleged statutory violations without necessitating a prolonged trial.